| Heart Failure (HF) |
1 |
1 |
| Heart |
0 |
0.74 |
| Cardiovascular Imaging |
0 |
0.69 |
| SGLT2 Inhibitor |
0 |
0.99 |
| Cardiovascular Risk Management |
0 |
0.95 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.49 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.41 |
| Food and Drug Administration (FDA) |
0 |
0.41 |
| Type 2 Diabetes Mellitus |
0 |
0.9 |
| Ejection Fraction |
0 |
0.98 |
| Cardiovascular disease |
0 |
0.08 |
| Grant |
0 |
0.08 |
| New York |
0 |
0.08 |